BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30
Bodhi Tree Biotechnology Inc
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.28+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.17M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.0820 (+41.00%)since Mar 11, 2026
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Bodhi Tree Biotechnology Inc reported revenue of $37.00K for the twelve months to Jun 30, 2026.
Revenue
$37.00K
TTM Q3 2026
Operating income
-$114.77K
TTM Q3 2026
EPS, diluted
-$0.01
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $7.17M
- P/E ratio
- –
- Price to sales
- 193.90
- Price to book
- 519.02
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $37.00K
- Net income
- -$116.03K
- EPS, diluted
- -$0.01
- Book value per share
- $0.00
- Diluted shares
- 25M
Two years at a glance
Fiscal years 2024 to 2025 and trailing twelve months, USD
Revenue
$37.00K
Operating income
-$114.77K
Net income
-$116.03K
EPS, diluted
-$0.01
Reported periodTrailing twelve months